A case of insulin autoimmune syndrome accompanied by hyperthyroidism is reported here.
The patient was a 43-yr-old woman diagnosed as having hyperthyroidism in 1971, and treated with methimazole for 60 days in 1976. She had never received insulin injections previously.
In August 1977, she was admitted due to hypoglycemic attacks. On admission, a 100g o-GTT revealed a diabetic tolerance curve. Her serum immunoreactive insulin (IRI) and C-peptide reactivity (CPR) showed extremely high levels such as 11, 600 μU/m/ and 19.5 ng/mi, respectively. Serum T
3 and T
4 showed thyrotoxic levels and autoantibodies to thyroid microsomes were positive. Anti-insulin antibodies in the IgG fraction were detected by gel filtration and radioimmunoelectrophoresis, and the light chain of the antibodies was predominantly of the kappa type. The percent 125I-insulin binding as an index of the antibody titer determined by the ethanol-precipitation method was significantly higher (64.4%) than in a control (12.6%), and a large amount of IRI (4, 980μU/ml) could be extracted from the serum obtained on the day of hypoglycemic attack.
The patient had frequently suffered from hypoglycemic attacks, from which she was thereafter relieved spontaneously coincident with a remarkable decrease in IRI and CPR.
One year later, when the hyperthyroidism was controlled with propylthiouracil, a glucose tolerance test revealed a borderline glucose curve. An insulin tolerance test (0.15 U/kg I. V.) showed high sensitivity to exogenous insulin (hypoglycemia at 35 min) and normal responses of serum cortisol, h-GH and plasma glucagon with a decrease in CPR of 38% of the initial value. On the other hand, antithyroid and anti-insulin antibody titers remained elevated, suggesting that the autoimmunity of the two diseases had continued during this time.
The pathogenesis of the insulin autoimmune syndrome in relation to hyperthyroidism is discussed.
View full abstract